Openbookopenbook
Equity
NGVT
+0.0 · +0.00%
USD · NYSE

Ingevity Corp(NGVT) Stock Analysis | Basic Materials

USD --+0.00%
Reward45Moderate
Risk50Moderate
75%Data
Thin 5% profit margin · Revenue down 5% YoY
Earnings Deterioration
Market Cap:2.42Bn
ⓘ
Reward Rating
45
Moderate
Reward Assessment
75% data coverage
Bottom 25% of stocksView factors
ⓘ
Risk Rating
50
Moderate
Risk Assessment
3 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on NGVT to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for NGVT, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $89.00.

What is Ingevity Corp?

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America.

NGVT · Verdict

Moderate reward · moderate risk

NGVT's standout is cash flow; balance sheet and valuation weigh on the picture.

Based on 88% data coverage

NGVT · Verdict

What’s working & what to watch

Strengths 1

  • Cash flow69/100

    23% free-cash-flow margin

Watchouts 4

  • Balance sheet34/100

    Net debt/EBITDA 31.1×

  • Valuation36/100

    P/E 10.0× · PEG 2.41

  • Profitability43/100

    -14% net margin · 30% ROE

  • Growth45/100

    Revenue -11.2% CAGR

Model-based scoring. For information only — not financial advice.

What is Ingevity Corp?

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The company is listed on the NYSE in USA, operating in the Basic Materials sector, with a market capitalisation of 2.42B, and a P/E ratio of 99.0x.

Financial Highlights

Investment Breakdown

Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (45)

The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Specialty Chemicals names that are close enough in size to make side-by-side comparison useful.

CCMid Cap / 2.4B market cap
Chemours Co
Compare
HWKNMid Cap / 2.5B market cap
Hawkins Inc
Compare
IOSPMid Cap / 2.3B market cap
Innospec Inc
Compare
Company Information
SectorBasic Materials
IndustrySpecialty Chemicals
Market Cap2.42B
P/E Ratio98.9718
Dividend YieldN/A
Beta1.18
Insider Activity
12M windowQuiet
Fewer than three real open-market insider trades in the last 12 months. Mechanical activity (option exercises, RSU vests) is excluded from the signal.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.